Beta-lactamase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9926336
SERIAL NO

15675253

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VENATORX PHARMACEUTICALS INC30 SPRING MILL DRIVE MALVERN PA 19355

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Burns, Christopher J Malvern, US 70 1106
Daigle, Denis Street, US 33 572
Hamrick, Jodie New Holland, US 16 120
Jackson, Randy W Livingston, US 21 550
Liu, Bin Plainsboro, US 1027 7414
McGarry, Daniel Malvern, US 32 560
Pevear, Daniel C Downingtown, US 51 609
Trout, Robert E Lee Collegeville, US 27 559

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 27, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 27, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00